N4 Pharma (GB:N4P) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
N4 Pharma PLC has reported a change in major holdings following a recent share placement, with Marc Mathenz acquiring a notable 8.36% voting rights, as per the 18 June 2024 notification. The company’s issued share capital has increased after the placement, with Mathenz participating in the transaction. The reporting was completed in Singapore on the date of the announcement.
For further insights into GB:N4P stock, check out TipRanks’ Stock Analysis page.